Shouxiangu(SH:603896) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-11-11 04:50Core Points - Zhejiang Shouxiangu Pharmaceutical Co., Ltd. will hold a Q3 2025 performance briefing on November 18, 2025, to discuss its operational results and financial status [2][4] - The meeting will be conducted via video recording combined with online interaction, allowing investors to submit questions in advance [3][7] - Key executives, including the Chairman and General Manager, will participate in the briefing [5] Meeting Details - The performance briefing is scheduled for November 18, 2025, from 13:00 to 14:30 [4] - It will take place at the Shanghai Stock Exchange Roadshow Center [4] - Investors can participate online and submit questions from November 11 to November 17, 2025 [7][8] Bond Interest Payment Announcement - The company announced that the "Shou 22 Convertible Bond" will start paying interest on November 17, 2025, for the period from November 17, 2024, to November 16, 2025 [11][17] - The interest rate for this period is set at 1%, meaning each bond with a face value of 100 RMB will yield 1.00 RMB in interest [17][23] - The bond's interest payment registration date is November 14, 2025, with the ex-dividend date also on November 17, 2025 [18][19] Bond Issuance Overview - The "Shou 22 Convertible Bond" was issued with a total scale of 398 million RMB and has a maturity of six years [12] - The bond's initial conversion price is 38.08 RMB per share, with the latest conversion price at 36.84 RMB per share [12][13] - The bond has a credit rating of "AA-" with a stable outlook [14][15]